Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Cindy L Vnencak-Jones
Affiliation
Vanderbilt University Medical Center
ORCID
Career Start Year
1987
Papers
125
H Index
37
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36450478
Impairments to executive function in emerging adults with Huntington disease.
J Neurol Neurosurg Psychiatry
2023
37407326
Preemptive Pharmacogenetic-Guided Metoprolol Management for Postoperative Atrial Fibrillation in Cardiac Surgery: The Preemptive Pharmacogenetic-Guided Metoprolol Management for Atrial Fibrillation in Cardiac Surgery Pilot Trial.
J Cardiothorac Vasc Anesth
2023
36503149
Assessments of Somatic Variant Classification Using the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists Guidelines: A Report from the Association for Molecular Pathology.
J Mol Diagn
2023
34240279
The first report of a JAK2 V617F-positive myeloproliferative neoplasm with initial manifestation as a rare pampiniform venous plexus thrombosis and review of the literature.
J Thromb Thrombolysis
2022
33048353
A Tutorial for Pharmacogenomics Implementation Through End-to-End Clinical Decision Support Based on Ten Years of Experience from PREDICT.
Clin Pharmacol Ther
2021
34834403
Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program.
J Pers Med
2021
33283233
Acute Myeloid Leukemia Case Harboring Unusual FLT3 Variant: Somatic vs Germline?
Lab Med
2021
31606278
CYP2D6 Genotype-guided Metoprolol Therapy in Cardiac Surgery Patients: Rationale and Design of the Pharmacogenetic-guided Metoprolol Management for Postoperative Atrial Fibrillation in Cardiac Surgery (PREEMPTIVE) Pilot Study.
J Cardiothorac Vasc Anesth
2020
30543839
Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases.
J Thorac Oncol
2019
29875428
The impact of variant classification on the clinical management of hereditary cancer syndromes.
Genet Med
2019
31184237
Clinicopathologic correlates of <i>MYD88</i> L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma.
Leuk Lymphoma
2019
31152546
PD-L1 Expression Patterns in Microsatellite Instability-High Intestinal Adenocarcinoma Subtypes.
Am J Clin Pathol
2019
29249244
Authors' Reply.
J Mol Diagn
2018
29423539
Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.
J Neurooncol
2018
29474982
Deciphering Elevated Microsatellite Alterations at Selected Tetra/Pentanucleotide Repeats, Microsatellite Instability, and Loss of Heterozygosity in Colorectal Cancers.
J Mol Diagn
2018
29310020
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia.
Leuk Res
2018
27993330
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
J Mol Diagn
2017
28278720
Comparison of BCR/ABL1 mRNA levels by quantitative real-time PCR in peripheral blood and bone marrow specimens of patients with chronic myelogenous leukemia.
Leuk Lymphoma
2017
27810331
Differences in Microsatellite Instability Profiles between Endometrioid and Colorectal Cancers: A Potential Cause for False-Negative Results?
J Mol Diagn
2017
27753663
Primary Carcinoid Tumor of the Renal Pelvis Arising From Intestinal Metaplasia: An Unusual Histogenetic Pathway?
Appl Immunohistochem Mol Morphol
2017
26732781
Concurrent and Clonally Related Pediatric Follicular Lymphoma and Burkitt Lymphoma in a 5-Year-Old Boy.
Lab Med
2016
27284491
Mutation profiles of synchronous colorectal cancers from a patient with Lynch syndrome suggest distinct oncogenic pathways.
J Gastrointest Oncol
2016
25801490
Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission.
Am J Hematol
2015
24186143
Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.
Mod Pathol
2014
31051723
Molecular testing of NSCLC using a platform for rapid detection of multiple oncogenetic mutations.
J Am Soc Cytopathol
2014
25337215
The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.
Int J Clin Exp Pathol
2014
25076300
Transformation of small B-cell lymphoma into large cell CD30âº, CD4âº, Epstein-Barr virus-negative lymphoma.
Arch Pathol Lab Med
2014
24599935
Beyond histology: translating tumor genotypes into clinically effective targeted therapies.
Clin Cancer Res
2014
24722917
Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling.
Breast Cancer Res Treat
2014
24651910
Endomyometriosis ("Uterus-like mass") in an XY Male: Case Report With Molecular Confirmation and Literature Review.
Int J Surg Pathol
2014
24300538
Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing.
Int J Gynecol Pathol
2014
23515407
Characteristics of lung cancers harboring NRAS mutations.
Clin Cancer Res
2013
24345920
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition.
Clin Cancer Res
2013
23949867
Maternal FMR1 premutation allele expansion and contraction in fraternal twins.
Am J Med Genet A
2013
23773459
Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.
Clin Colorectal Cancer
2013
22238169
A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel.
Clin Infect Dis
2012
22798288
BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors.
Cancer Discov
2012
22773810
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.
Proc Natl Acad Sci U S A
2012
22536370
Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials.
PLoS One
2012
22588608
Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
Clin Pharmacol Ther
2012
22659680
Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers.
Bone Marrow Transplant
2012
21227397
A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer.
J Mol Diagn
2011
22180717
Neuroendocrine and squamous colonic composite carcinoma: case report with molecular analysis.
World J Gastroenterol
2011
20022264
Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial.
J Heart Lung Transplant
2010
20496075
A novel BMPR2 mutation associated with pulmonary arterial hypertension in an octogenarian.
Lung
2010
19880300
T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.
Respir Med
2010
19531247
Copy-number variation in BMPR2 is not associated with the pathogenesis of pulmonary arterial hypertension.
BMC Med Genet
2009
19582766
Bone marrow engraftment studies.
Curr Protoc Hum Genet
2009
19797613
Competency-based education for the molecular genetic pathology fellow: a report of the association for molecular pathology training and education committee.
J Mol Diagn
2009
19745614
A B-cell lymphoma diagnosed in "floater" tissue: implications of the diagnosis and resolution of a laboratory error.
Am J Med Sci
2009
1 - 50 of 125
Column Actions
Search
Recommended Authors
Qiulu Pan
Technical University of Munich
Career Start Year
1999
Number of shared co-authors
3
Lawrence J Jennings
Northwestern University Feinberg School of Medicine
Career Start Year
1998
Number of shared co-authors
1
Jason D Merker
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year
1998
Number of shared co-authors
4
Gordana Raca
Children's Hospital Los Angeles
Career Start Year
1997
Number of shared co-authors
6
Matthew J Ferber
Mayo Clinic
Career Start Year
1997
Number of shared co-authors
1
Sean McGrath
Harvard T.H. Chan School of Public Health
Career Start Year
1996
Number of shared co-authors
3
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
6
Doris Steinemann
Hannover Medical School
Career Start Year
1994
Number of shared co-authors
0
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year
1992
Number of shared co-authors
3
Julie M Gastier-Foster
Baylor College of Medicine
Career Start Year
1992
Number of shared co-authors
8
Noralane M Lindor
Mayo Clinic
Career Start Year
1992
Number of shared co-authors
9
Gregory J Tsongalis
Dartmouth Health and the Dartmouth Cancer Center, USA Geisel School of Medicine
Career Start Year
1990
Number of shared co-authors
3
Shrikant Mane
Yale School of Medicine
Career Start Year
1989
Number of shared co-authors
1
Richard D Press
Oregon Health and Science University
Career Start Year
1988
Number of shared co-authors
3
Karen E Weck
University of North Carolina at Chapel Hill
Career Start Year
1987
Number of shared co-authors
8
Leslie G Biesecker
National Human Genome Research Institute, National Institutes of Health
Career Start Year
1987
Number of shared co-authors
6
Hanna Rennert
New York NewYork-Presbyterian Hospital
Career Start Year
1986
Number of shared co-authors
0
David A Wheeler
Baylor College of Medicine
Career Start Year
1984
Number of shared co-authors
15
Arupa Ganguly
Perelman School of Medicine, University of Pennsylvania
Career Start Year
1983
Number of shared co-authors
0
Sharon E Plon
Baylor College of Medicine
Career Start Year
1982
Number of shared co-authors
9
Peter K Rogan
CytoGnomix Inc.
Career Start Year
1981
Number of shared co-authors
1
Michael Dean
National Cancer Institute
Career Start Year
1980
Number of shared co-authors
4
Wayne W Grody
David Geffen School of Medicine, university of california los angeles
Career Start Year
1980
Number of shared co-authors
2
John W Belmont
Baylor College of Medicine
Career Start Year
1979
Number of shared co-authors
5
Carolyn Sue Richards
Oregon Health & Science University (OHSU)
Career Start Year
1978
Number of shared co-authors
3
Stephen N Thibodeau
Mayo Clinic
Career Start Year
1978
Number of shared co-authors
4
Graeme Suthers
University of Adelaide
Career Start Year
1977
Number of shared co-authors
0
Javier Ben??tez
Instituto de Salud Carlos III
Career Start Year
1975
Number of shared co-authors
1
John J Mulvihill
University of Oklahoma
Career Start Year
1968
Number of shared co-authors
2
Albert de la Chapelle
The Ohio State University Comprehensive Cancer Center
Career Start Year
1961
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
John A Phillips
Vanderbilt University Medical Center
Co-authored papers
15
Dora Dias-Santagata
Co-authored papers
4
Josh F Peterson
Vanderbilt University Medical Center
Co-authored papers
3
Marilyn M Li
Children's Hospital of Philadelphia
Co-authored papers
3
Robert A Parker
Massachusetts General Hospital
Co-authored papers
3
Somak Roy
University of Cincinnati College of Medicine
Co-authored papers
3
Gregory J Riely
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Vincent A Miller
Injury Prevention Research Center, University of North Carolina
Co-authored papers
2
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Marc Beller
Center for Precision Medicine, Vanderbilt University Medical Center
Co-authored papers
2
Lecia V Sequist
Massachusetts General Hospital Cancer Center, Harvard Medical School
Co-authored papers
2
Mia A Levy
Rush University Cancer Center, Rush University Medical Center
Co-authored papers
2
Zhongming Zhao
Center for Precision Health, The University of Texas Health Science Center at Houston
Co-authored papers
2
Miklos D Kertai
Vanderbilt University Medical Center
Co-authored papers
2
Jonathan P Wanderer
Vanderbilt University Medical Center
Co-authored papers
2
Shashikant Kulkarni
Centene Center for Health Transformation, Centene Corporation
Co-authored papers
2
Ashish S Shah
Vanderbilt University Medical Center
Co-authored papers
2
Matthew S Shotwell
Vanderbilt University Medical Center
Co-authored papers
2
Cheryl L Gatto
Vanderbilt University School of Medicine
Co-authored papers
2
Sara L Van Driest
National Institutes of Health
Co-authored papers
2
Anthony J Iafrate
Massachusetts General Hospital
Co-authored papers
2
Robert J Weil
Rhode Island Hospital
Co-authored papers
2
Asli Ozdas
Vanderbilt University Medical Center
Co-authored papers
2
Kathryn M Edwards
Vanderbilt University Medical Center
Co-authored papers
2
Andrea H Ramirez
Vanderbilt University Medical Center
Co-authored papers
1
Guillermo Garcia-Manero
MD Anderson Cancer Center
Co-authored papers
1
Catherine E Cottrell
Nationwide Children's Hospital
Co-authored papers
1
Dan M Roden
Vanderbilt University Medical Center
Co-authored papers
1
Janos L Mathe
Vanderbilt University Medical Center
Co-authored papers
1
Pierre P Massion
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Co-authored papers
1
1 - 30